Wells Fargo Starts Kezer Life Sciences (KZR) at Overweight
Tweet
Share
E-mailGet Alerts KZR Hot Sheet
Price: $7.29 --0%
Rating Summary:
1 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
1 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Wells Fargo analyst Chris M. Carey initiates coverage on Kezer Life Sciences (NASDAQ: KZR) with a Overweight rating and a price target of $19.00.
For an analyst ratings summary and ratings history on Kezer Life Sciences click here. For more ratings news on Kezer Life Sciences click here.
Shares of Kezer Life Sciences closed at $13.44 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AMD (AMD) to offer senior notes in four parts
- BMO Capital Starts Energy Fuels (UUUU) at Outperform
- JPMorgan Resumes SanDisk (SNDK) at Overweight
Create E-mail Alert Related Categories
New CoverageRelated Entities
Wells FargoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
